UPDATED 20.02.2014 11:53

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2005. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 25026 244 0.97 1 0.00 1 0.00 6 0.02 25 0.10 31 0.12 26 0.10 154 0.62
I 23575 - - - - - - - - - - - - - - - -
II 1195 15 0.06 - - - - - - - - - - 1 - 14 0.06
III 210 210 0.84 - - - - 3 0.01 18 0.07 28 0.11 23 0.09 138 0.55
IV 18 18 0.07 1 - 1 - 2 0.01 7 0.03 3 0.01 2 0.01 2 0.01
V 1 1 - - - - - 1 - - - - - - - - -
Inadequate 27 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 7590 91 1.20 1 0.01 1 0.01 - - 14 0.18 18 0.24 13 0.17 44 0.58
Negative1 6976 6 0.08 - - - - - - - - - - - - 6 0.08
Positive2 614 85 1.12 1 0.01 1 0.01 - - 14 0.18 18 0.24 13 0.17 38 0.50
Total 32616 335 1.03 2 0.01 2 0.01 6 0.02 39 0.12 49 0.15 39 0.12 198 0.61

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.